跳至主要内容
临床试验/CTRI/2024/03/064726
CTRI/2024/03/064726尚未招募不适用

Prevention of neonatal hypoglycemias with oral dextrose gel among high-risk neonates admitted in Tertiary care centre

Dr. Uthayashree P1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
prevention of hypoglycemia among high risk neonates

研究概览

简要总结

Glucose is the principal substrate for cerebral metabolism, and neonatal hypoglycemia causes damage in neuroglial cells and leads to adverse neurodevelopmental outcome.Approximately 25% of neonates are at risk for neonatal hypoglycemia. Some of these infants fail to normalize blood glucose levels by feed alone and require intravenous dextrose therapy. Preterm infants, small for gestational age (SGA), large for gestational age (LGA), infants of diabetic mothers are at high risk of requiring intravenous dextrose therapy due to persistent hypoglycemia.

 In this study, we aim to study about the use of oral dextrose gel (40%) in preventing hypoglycemia in at risk neonates which helps in better neurodevelopmental outcome and the use of oral dextrose gel in preventing hospital admission and early initiation of breastfeeding

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
0.00 Day(s) 至 7.00 Day(s)(—)
性别
All

入选标准

  • •preterm, small for gestational age, large for gestational age, infants of diabetic mothers.

排除标准

  • •sepsis, endocrine causes.

结局指标

主要结局

prevention of hypoglycemia among high risk neonates

时间窗: every 6th hourly for 72 hours of life

次要结局

  • EARLY DISCHARGE RATE(1 week)

研究者

发起方
Dr. Uthayashree P
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrUthayashree P

Gulbarga institute of medical sciences

研究点 (1)

Loading locations...

相似试验